The analyst believes that growth and the achievement of objectives are on track. Operating profit was higher in the 1st half of 2024 and organic sales growth forecasts have been revised upwards.

UBS confirms its Buy recommendation and raises its price target to 93.25 E (from 92 E), which represents a potential upside of 21%.

' H1 2024 showed continued operational improvements and a message of confidence for FY 2024 and FY 2025' says UBS.

' Solid performance driven by North America. Organic revenue growth forecasts have been raised' says the analyst firm.

Copyright (c) 2024 All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.